Tristel Plc (TSTL) Stock Rating Reaffirmed by FinnCap

FinnCap reissued their corporate rating on shares of Tristel Plc (LON:TSTL) in a research report sent to investors on Tuesday, October 3rd.

Tristel Plc (LON:TSTL) remained flat at GBX 282.50 during trading on Tuesday. 7,303 shares of the company were exchanged. Tristel Plc has a 52-week low of GBX 140.00 and a 52-week high of GBX 326.01. The company has a 50-day moving average of GBX 279.47 and a 200 day moving average of GBX 232.01. The company’s market capitalization is GBX 118.81 million.

COPYRIGHT VIOLATION NOTICE: This piece was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/10/14/tristel-plc-tstl-stock-rating-reaffirmed-by-finncap.html.

In other news, insider Elizabeth Dixon sold 10,000 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of GBX 273 ($3.59), for a total transaction of £27,300 ($35,892.72).

Tristel Plc Company Profile

Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company’s technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals.

Receive News & Ratings for Tristel Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel Plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply